Literature DB >> 8858526

The biology of meningiomas.

I E McCutcheon1.   

Abstract

Meningiomas, long neglected as a subject for biological studies, are now being examined more widely as their potential for clinical recurrence and malignancy has been recognized. Most laboratory studies have focused on descriptive analyses of the content of various molecules in ex vivo specimens removed at surgery. Perturbative experiments using cultured cells are possible, but they are complicated by senescence of the cells. The respective importance of the sex steroids (estrogen, progesterone, and androgens), classical growth factors, angiogenic factors, and proteolytic enzymes in the biological behavior of meningiomas is now apparent and is coming under more detailed scrutiny. As general theories of neoplasia crystallize in other systems, the ability of meningiomas to proliferate, invade, and provoke neovascularization will be better understood.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8858526     DOI: 10.1007/bf00165650

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  56 in total

1.  Immunocytochemical study of progesterone receptor in human meningioma.

Authors:  M Perrot-Applanat; M T Groyer-Picard; M Kujas
Journal:  Acta Neurochir (Wien)       Date:  1992       Impact factor: 2.216

2.  Implantation of human meningiomas into the subrenal capsule of the nude mouse. A model for studies of tumor growth.

Authors:  A Medhkour; M Van Roey; R A Sobel; H J Fingert; J Lee; R L Martuza
Journal:  J Neurosurg       Date:  1989-10       Impact factor: 5.115

3.  High incidence of somatostatin receptors in human meningiomas: biochemical characterization.

Authors:  J C Reubi; R Maurer; J G Klijn; S Z Stefanko; J A Foekens; G Blaauw; M A Blankenstein; S W Lamberts
Journal:  J Clin Endocrinol Metab       Date:  1986-08       Impact factor: 5.958

4.  Enhanced expression of the sis and c-myc oncogenes in human meningiomas.

Authors:  K Kazumoto; M Tamura; H Hoshino; Y Yuasa
Journal:  J Neurosurg       Date:  1990-05       Impact factor: 5.115

5.  Elevated levels of M(r) 92,000 type IV collagenase in human brain tumors.

Authors:  J S Rao; P A Steck; S Mohanam; W G Stetler-Stevenson; L A Liotta; R Sawaya
Journal:  Cancer Res       Date:  1993-05-15       Impact factor: 12.701

6.  Presence of dopamine D1 receptors and absence of dopamine D2 receptors in human cerebral meningioma tissue.

Authors:  U M Schrell; P Nomikos; R Fahlbusch
Journal:  J Neurosurg       Date:  1992-08       Impact factor: 5.115

7.  Immunohistochemical detection of female sex hormone receptors in meningiomas: correlation with clinical and histological features.

Authors:  A Brandis; S Mirzai; M Tatagiba; G F Walter; M Samii; H Ostertag
Journal:  Neurosurgery       Date:  1993-08       Impact factor: 4.654

8.  Estrogen-receptor protein in intracranial meningiomas.

Authors:  M S Donnell; G A Meyer; W L Donegan
Journal:  J Neurosurg       Date:  1979-04       Impact factor: 5.115

9.  Somatostatin inhibits the activity of adenylate cyclase in cultured human meningioma cells and stimulates their growth.

Authors:  J W Koper; R Markstein; C Kohler; D J Kwekkeboom; C J Avezaat; S W Lamberts; J C Reubi
Journal:  J Clin Endocrinol Metab       Date:  1992-03       Impact factor: 5.958

10.  Androgen receptor expression in meningiomas.

Authors:  R S Carroll; J Zhang; K Dashner; M Sar; E M Wilson; P M Black
Journal:  J Neurosurg       Date:  1995-03       Impact factor: 5.115

View more
  6 in total

1.  Expression of TGFalpha in meningiomas.

Authors:  J Halper; C Jung; A Perry; H Suliman; M P Hill; B Scheithauer
Journal:  J Neurooncol       Date:  1999       Impact factor: 4.130

Review 2.  Medical therapies for meningiomas.

Authors:  Patrick Y Wen; Eudocia Quant; Jan Drappatz; Rameen Beroukhim; Andrew D Norden
Journal:  J Neurooncol       Date:  2010-09-04       Impact factor: 4.130

3.  Long-term outcome of moderate hypofractionated stereotactic radiotherapy for meningiomas.

Authors:  Ernesto Maranzano; Lorena Draghini; Michelina Casale; Fabio Arcidiacono; Paola Anselmo; Fabio Trippa; Cesare Giorgi
Journal:  Strahlenther Onkol       Date:  2015-10-21       Impact factor: 3.621

4.  Factors Related to the Post-operative Recurrence of Atypical Meningiomas.

Authors:  Wu Ye; Tang Ding-Zhong; Yang Xiao-Sheng; Zhan Ren-Ya; Li Yi
Journal:  Front Oncol       Date:  2020-04-15       Impact factor: 6.244

5.  [68Ga]-DOTATOC-PET/CT for meningioma IMRT treatment planning.

Authors:  Barbara Gehler; Frank Paulsen; Mehmet O Oksüz; Till-Karsten Hauser; Susanne M Eschmann; Roland Bares; Christina Pfannenberg; Michael Bamberg; Peter Bartenstein; Claus Belka; Ute Ganswindt
Journal:  Radiat Oncol       Date:  2009-11-18       Impact factor: 3.481

Review 6.  Emerging Medical Treatments for Meningioma in the Molecular Era.

Authors:  Fares Nigim; Hiroaki Wakimoto; Ekkehard M Kasper; Linda Ackermans; Yasin Temel
Journal:  Biomedicines       Date:  2018-08-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.